Covid-19 Research

Special Issue

RespiraScience: Lung Health, Pulmonary Care & Translational Studies

A JBRES Special Issue dedicated to rigorous, outcome-oriented advances in respiratory medicine—linking biomarkers, precision pulmonology, translational research, and innovative therapies to strengthen lung health, disease management, and patient outcomes.

Home › Special Issues › RespiraScience
Submit Manuscript All Special Issues
JBRES Special Issue • Respiratory & Lung Health
Special Issue Title

RespiraScience: Lung Health, Pulmonary Care & Translational Studies

This Special Issue of the Journal of Biomedical Research & Environmental Sciences (JBRES) invites high-quality submissions that strengthen the evidence base for lung health and pulmonary diseases. We welcome work that advances biomarkers & precision tools, clarifies disease mechanisms, and demonstrates translational & real-world effectiveness across diverse respiratory conditions and care settings.

Biomarkers & Precision Tools
Blood eosinophils, FeNO, sputum transcriptomics, ECM remodeling markers, ctDNA, AI-driven diagnostics, predictive signatures.
Pulmonary Care & Translation
COPD/asthma biologics, ILD/fibrosis therapies, RSV/pneumonia interventions, digital monitoring, exacerbation prevention, implementation science.
Submit to This Special Issue Submission Guidelines Peer Review Policy

About this Special Issue

Pulmonary research is strongest when it connects biomarker insights with therapeutic innovation and practical outcomes. This Special Issue focuses on lung health & translational pulmonology—from precision management of COPD, asthma, and ILD to emerging therapies for fibrosis and infections, and policy-relevant translation. We especially welcome submissions that report transparent methods, robust endpoints, and insights that can improve respiratory care, equity, and long-term well-being.

Preference is given to studies with clear outcomes (exacerbation rates, FEV1, DLCO, progression-free survival), robust analysis, and a concise “What this changes in practice” statement.

Topics of interest

Submissions may address (but are not limited to):

COPD & Asthma Precision Management Interstitial Lung Disease & Pulmonary Fibrosis Biomarkers in Respiratory Diseases Eosinophilic & Inflammatory Endotypes Biologics & Targeted Therapies RSV, Pneumonia & Respiratory Infections Idiopathic Pulmonary Fibrosis Advances Digital Health & Wearable Monitoring ECM Remodeling & Fibrosis Mechanisms Translational Studies in Lung Repair Exacerbation Prevention Strategies Real-World Evidence in Pulmonology

Article types accepted

  • Original Research Articles
  • Clinical Trials & Intervention Studies
  • Observational & Population Studies
  • Review Articles
  • Systematic Reviews & Meta-Analyses
  • Mini-Reviews
  • Short Communications
  • Case Studies (where appropriate)
Tip: Include (1) primary/secondary outcomes, (2) a brief methods transparency note (preregistration/data availability if applicable), and (3) a “Clinical/Community Relevance” paragraph.

Why submit to this Special Issue?

  • Precision-forward visibility: your work is presented alongside leading lung health and translational pulmonary research.
  • Efficient editorial pathway: JBRES targets rapid peer review (7–14 days where applicable).
  • Permanent DOI: accepted articles receive DOI for strong citation continuity.
  • Open access reach: broad discoverability for clinicians, researchers, and respiratory teams.
  • Author support: clear guidance through review, proofing, and publication.
Ready to submit?
Submit online, or share an abstract for an editorial scope check (methods + outcomes summary preferred).
Submit Manuscript Email Abstract
Submission Portal Submission Instructions Aims & Scope Archive
Alternative submission emails: [email protected] | [email protected]
License (upon publication): Creative Commons CC BY 4.0
Publish with JBRES — Peer-reviewed, multidisciplinary Open Access with rapid review, DOI, and global visibility.
Double-Blind CrossRef DOI Discoverable
Submit Manuscript Membership